GALAPAGOS
Live / Registered — Registered — partial Section 8 accepted (as of 24 Feb 2026)
What this means for you
Registered since 22 Oct 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88110392
- Registration number
- 5888518
- Mark type
- Stylized text
- Filed
- 10 Sept 2018
- Published for opposition
- 06 Aug 2019
- Registered
- 22 Oct 2019
- Attorney of record
- Alexandra MacKay
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical substances and preparations for human use, namely, for the treatment of [ bone cartilage and joint disease, ] autoinflammation diseases, autoimmune diseases, proliferative diseases, [ endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, ] lupus [ , uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes ] ; biopharmaceutical substances and preparations for human use, namely, for the treatment of [ bone cartilage and joint disease, ] autoinflammation diseases, autoimmune diseases, proliferative diseases, [ endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, ] lupus [ , uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes ]
- Class 042 — Scientific and technological services: [ medical and scientific research services; industrial research services in the field of assay development, target discovery and validation, drug development, and medicinal chemistry; pharmaceutical and biopharmaceutical research and development services; medical and scientific research, namely, the examination and testing of genes; development, laboratory analysis, and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; development, laboratory analysis, and testing of medicaments; the development of clinical assays, cellular tests, testing kits, diagnostic kits, and companion diagnostics for evaluating pharmaceutical and biopharmaceutical products of others; development of computer databases in the medical, pharmaceutical and biopharmaceutical fields and gathering of data to populate same via collection of medical, pharmaceutical, biopharmaceutical research and clinical trial data; and gene bank services for research purposes ]
- Class 044 — Medical, beauty and agricultural services: [ medical services; medical and pharmaceutical advisory and consultancy services; gene bank services ]
Owner
- Galapagos N.V., Mechelen, BE
- Galapagos N.V., Mechelen, BE
- Galapagos N.V., Mechelen, BE
Prior registrations
Prosecution history
- 24 Feb 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 24 Feb 2026 — REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
- 23 Feb 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Oct 2025 — TEAS SECTION 8 RECEIVED
- 22 Oct 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 22 Oct 2019 — REGISTERED-PRINCIPAL REGISTER
- 06 Aug 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Aug 2019 — PUBLISHED FOR OPPOSITION
- 17 Jul 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Jul 2019 — ELECTRONIC RECORD REVIEW COMPLETE
- 28 Jun 2019 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 24 Jun 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Jun 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Jun 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Jun 2019 — TEAS VOLUNTARY AMENDMENT RECEIVED